Clinical Trial Update: Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction [NA]

View source ↗

Summary

Results from a completed pilot feasibility study evaluated the safety and potential efficacy of the interleukin-1 receptor antagonist anakinra in heart failure …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Anakinra (Kineret) (Anakinra)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Heart Failure | NA | Status: COMPLETED | Results posted: 2016-04-07